The groundbreaking Lumea BxChip® is now available in select European markets. An article in the American Journal of Clinical Pathology recently praised the chip for its ability to reduce cost and increase efficiency...
Read More
*BxLink has not been approved by the FDA for digital primary diagnosis. Refer to CAP guidelines regarding the use of digital pathology technologies.
Recent Comments